Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.

Kirsten E PetersWendy A DavisJun ItoKaye WinfieldThomas StollScott D BringansRichard J LipscombeTimothy M E Davis

Published in: Diabetes care (2017)

The current study has identified novel plasma biomarkers (apoA4, CD5L, C1QB, and IBP3) that may improve the prediction of rapid decline in renal function independently of recognized clinical risk factors in type 2 diabetes.

Keyphrases

type diabetes
phase ii
risk factors
cardiovascular disease
glycemic control
clinical trial
open label
insulin resistance
adipose tissue
loop mediated isothermal amplification
phase iii
bioinformatics analysis